The 'Update on IL-17 function and targeting' session by Prof. Pierre Miossec (France) in Lisbon will cover new results which expand the understanding of the effect of IL-17 at the systemic level with focus on vessels and liver.
Since this lecture, new progress has revealed that IL-17 in combination with TNF induces migration of inflammatory cells to the liver, independently of IL-6. Increased levels of bioactive IL-17 are predictive of a cardio-vascular event. New anti-IL-17 drugs have been registered and new indications are under evaluation.
Watch Prof. Pierre Miossec's plenary lecture from 2016: IL-17: From Discovery To Targeting